TABLE 5.

Tolerability of products evaluated by patients through a questionnaire based on a 10 items scale: From 1 (none) to 10 (a lot).

	The use/consumption of the product/s is problematic
		Group A (n = 44)	Group B (n = 20)
None	1	37 (84.1%)	16 (80.0%)
↓	2	3 (6.8%)	2 (10.0%)
	3	0	1 (5.0%)
	4	0	0
	5	0	0
	6	2 (4.5%)	0
	7	0	1 (5.0%)
	8	1 (2.3%)	0
	9	1 (2.3%)	0
A lot	10	0	0

	Adverse gastro‐intestinal effects
		Group A (n = 44)	Group B (n = 17)
None	1	38 (86.4%)	16 (94.1%)
↓	2	4 (9.1%)	1 (5.9%)
	3	1 (2.3%)	0
	4	0	0
	5	0	0
	6	0	0
	7	0	0
	8	0	0
	9	1 (2.3%)	0
A lot	10	0	0